YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ) Gross margin 2021–2025
YUBO INTERNATIONAL BIOTECH LIMITED (YBGJ) gross margin by fiscal year — reported gross profit divided by reported revenue.
66.1%FY2025 · since FY2021: 65.9% → 66.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 66.1% | -10.2 pp |
| FY2024 | 76.3% | +7.0 pp |
| FY2023 | 69.3% | +18.8 pp |
| FY2022 | 50.5% | -15.5 pp |
| FY2021 | 65.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More YBGJ financial trends
YBGJ RevenueYBGJ Net incomeYBGJ Net marginYBGJ Gross profitYBGJ Operating incomeYBGJ Operating marginYBGJ Operating cash flowYBGJ Free cash flowYBGJ Capital expendituresYBGJ Return on equityYBGJ Stock buybacksYBGJ Dividends paidYBGJ Total assetsYBGJ Total liabilitiesYBGJ Shareholders’ equityYBGJ overview →